Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients - Rech, Jürgen; Hueber, Axel; Ostergaard, Mikkel; Tascilar, Koray; Hagen, Melanie; Mendez, Larissa Valor; Kleyer, Arnd; Krönke, Gerhard; Simon, David; Schönau, Verena; Hueber, Axel; Kleinert, Stefan; et al. (ARTHRITIS & RHEUMATOLOGY, 2021)
CRIS-Team WoS Importer:2022-03-11